Resistance diagnosis and the changing economics of antibiotic discovery.

Journal Article (Review)

Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the quantity of antibiotics sold. Advances in the science and technology underpinning rapid resistance diagnostics can therefore be expected to spur efforts to discover and develop new antibiotics, especially those with a narrow spectrum of activity that would otherwise fail to find a market.

Full Text

Duke Authors

Cited Authors

  • McAdams, D

Published Date

  • January 10, 2017

Published In

Volume / Issue

  • 1388 / 1

Start / End Page

  • 18 - 25

PubMed ID

  • 28072904

Electronic International Standard Serial Number (EISSN)

  • 1749-6632

International Standard Serial Number (ISSN)

  • 0077-8923

Digital Object Identifier (DOI)

  • 10.1111/nyas.13303

Language

  • eng